LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article ; Online: Proton pump inhibitors.

    Jenkins, Danny / Modolell, Ines

    BMJ (Clinical research ed.)

    2023  Volume 383, Page(s) e070752

    MeSH term(s) Humans ; Proton Pump Inhibitors/adverse effects
    Chemical Substances Proton Pump Inhibitors
    Language English
    Publishing date 2023-11-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj-2022-070752
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett's esophagus.

    Vithayathil, Mathew / Modolell, Ines / Ortiz-Fernandez-Sordo, Jacobo / Pappas, Apostolos / Januszewicz, Wladyslaw / O'Donovan, Maria / Bianchi, Michele / White, Jonathan R / Kaye, Philip / Ragunath, Krish / di Pietro, Massimiliano

    Endoscopy

    2023  Volume 55, Issue 6, Page(s) 491–498

    Abstract: BACKGROUND : Endoscopic surveillance of Barrett's esophagus (BE) with Seattle protocol biopsies is time-consuming and inadequately performed in routine practice. There is no recommended procedural time for BE surveillance. We investigated the duration of ...

    Abstract BACKGROUND : Endoscopic surveillance of Barrett's esophagus (BE) with Seattle protocol biopsies is time-consuming and inadequately performed in routine practice. There is no recommended procedural time for BE surveillance. We investigated the duration of surveillance procedures with adequate tissue sampling and effect on dysplasia detection rate (DDR). METHODS : We performed post hoc analysis from the standard arm of a crossover randomized controlled trial recruiting patients with BE (≥C2 and/or ≥M3) and no clearly visible dysplastic lesions. After inspection with white-light imaging, targeted biopsies of subtle lesions and Seattle protocol biopsies were performed. Procedure duration and biopsy number were stratified by BE length. The effect of endoscopy-related variables on DDR was assessed by multivariable logistic regression. RESULTS : Of 142 patients recruited, 15 (10.6 %) had high grade dysplasia/intramucosal cancer and 15 (10.6 %) had low grade dysplasia. The median procedural time was 16.5 minutes (interquartile range 14.0-19.0). Endoscopy duration increased by 0.9 minutes for each additional 1 cm of BE length. Seattle protocol biopsies had higher sensitivity for dysplasia than targeted biopsies (86.7 % vs. 60.0 %;
    MeSH term(s) Humans ; Barrett Esophagus/pathology ; Esophageal Neoplasms/pathology ; Esophagoscopy/methods ; Biopsy/methods ; Hyperplasia
    Language English
    Publishing date 2023-01-19
    Publishing country Germany
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 80120-3
    ISSN 1438-8812 ; 0013-726X
    ISSN (online) 1438-8812
    ISSN 0013-726X
    DOI 10.1055/a-2015-8883
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.

    di Pietro, Massimiliano / Modolell, Ines / O'Donovan, Maria / Price, Catherine / Pilonis, Nastazja D / Debiram-Beecham, Irene / Fitzgerald, Rebecca C

    The lancet. Gastroenterology & hepatology

    2020  Volume 5, Issue 9, Page(s) 805–806

    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Barrett Esophagus/diagnosis ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Deglutition Disorders/etiology ; Esophageal Neoplasms/diagnosis ; Esophagoscopy ; Gastroscopy ; Humans ; Middle Aged ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Stomach Neoplasms/diagnosis ; Surgical Sponges ; Triage/methods
    Keywords covid19
    Language English
    Publishing date 2020-07-30
    Publishing country Netherlands
    Document type Letter ; Research Support, Non-U.S. Gov't
    ISSN 2468-1253
    ISSN (online) 2468-1253
    DOI 10.1016/S2468-1253(20)30242-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett’s esophagus

    Vithayathil, Mathew / Modolell, Ines / Ortiz-Fernandez-Sordo, Jacobo / Pappas, Apostolos / Januszewicz, Wladyslaw / O’Donovan, Maria / Bianchi, Michele / White, Jonathan R. / Kaye, Philip / Ragunath, Krish / di Pietro, Massimiliano

    Endoscopy

    2023  Volume 55, Issue 06, Page(s) 491–498

    Abstract: Background : Endoscopic surveillance of Barrett’s esophagus (BE) with Seattle protocol biopsies is time-consuming and inadequately performed in routine practice. There is no recommended procedural time for BE surveillance. We investigated the duration ... ...

    Abstract Background : Endoscopic surveillance of Barrett’s esophagus (BE) with Seattle protocol biopsies is time-consuming and inadequately performed in routine practice. There is no recommended procedural time for BE surveillance. We investigated the duration of surveillance procedures with adequate tissue sampling and effect on dysplasia detection rate (DDR).
    Methods : We performed post hoc analysis from the standard arm of a crossover randomized controlled trial recruiting patients with BE (≥C2 and/or ≥M3) and no clearly visible dysplastic lesions. After inspection with white-light imaging, targeted biopsies of subtle lesions and Seattle protocol biopsies were performed. Procedure duration and biopsy number were stratified by BE length. The effect of endoscopy-related variables on DDR was assessed by multivariable logistic regression.
    Results : Of 142 patients recruited, 15 (10.6 %) had high grade dysplasia/intramucosal cancer and 15 (10.6 %) had low grade dysplasia. The median procedural time was 16.5 minutes (interquartile range 14.0–19.0). Endoscopy duration increased by 0.9 minutes for each additional 1 cm of BE length. Seattle protocol biopsies had higher sensitivity for dysplasia than targeted biopsies (86.7 % vs. 60.0 %; P  = 0.045). Longer procedural time was associated with increased likelihood of dysplasia detection on quadrantic biopsies (odds ratio [OR] 1.10, 95 %CI 1.00–1.20, P  = 0.04), and for patients with BE > 6 cm also on targeted biopsies (OR 1.21, 95 %CI 1.04–1.40; P  = 0.01).
    Conclusions : In BE patients with no clearly visible dysplastic lesions, longer procedural time was associated with increased likelihood of dysplasia detection. Adequate time slots are required to perform good-quality surveillance and maximize dysplasia detection.
    Language English
    Publishing date 2023-01-19
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 80120-3
    ISSN 1438-8812 ; 0013-726X
    ISSN (online) 1438-8812
    ISSN 0013-726X
    DOI 10.1055/a-2015-8883
    Database Thieme publisher's database

    More links

    Kategorien

  5. Article ; Online: Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's Esophagus.

    Vithayathil, Mathew / Modolell, Ines / Ortiz-Fernandez-Sordo, Jacobo / Oukrif, Dahmane / Pappas, Apostolos / Januszewicz, Wladyslaw / O'Donovan, Maria / Hadjinicolaou, Andreas / Bianchi, Michele / Blasko, Adrienn / White, Jonathan / Kaye, Philip / Novelli, Marco / Wernisch, Lorenz / Ragunath, Krish / di Pietro, Massimiliano

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2022  Volume 20, Issue 11, Page(s) 2514–2523.e3

    Abstract: Background & aims: Dysplasia in Barrett's esophagus often is invisible on high-resolution white-light endoscopy (HRWLE). We compared the diagnostic accuracy for inconspicuous dysplasia of the combination of autofluorescence imaging (AFI)-guided probe- ... ...

    Abstract Background & aims: Dysplasia in Barrett's esophagus often is invisible on high-resolution white-light endoscopy (HRWLE). We compared the diagnostic accuracy for inconspicuous dysplasia of the combination of autofluorescence imaging (AFI)-guided probe-based confocal laser endomicroscopy (pCLE) and molecular biomarkers vs HRWLE with Seattle protocol biopsies.
    Methods: Barrett's esophagus patients with no dysplastic lesions were block-randomized to standard endoscopy (HRWLE with the Seattle protocol) or AFI-guided pCLE with targeted biopsies for molecular biomarkers (p53 and cyclin A by immunohistochemistry; aneuploidy by image cytometry), with crossover to the other arm after 6 to 12 weeks. The primary end point was the histologic diagnosis from all study biopsies (trial histology). A sensitivity analysis was performed for overall histology, which included diagnoses within 12 months from the first study endoscopy. Endoscopists were blinded to the referral endoscopy and histology results. The primary outcome was diagnostic accuracy for dysplasia by real-time pCLE vs HRWLE biopsies.
    Results: Of 154 patients recruited, 134 completed both arms. In the primary outcome analysis (trial histology analysis), AFI-guided pCLE had similar sensitivity for dysplasia compared with standard endoscopy (74.3%; 95% CI, 56.7-87.5 vs 80.0%; 95% CI, 63.1-91.6; P = .48). Multivariate logistic regression showed pCLE optical dysplasia, aberrant p53, and aneuploidy had the strongest correlation with dysplasia (secondary outcome). This 3-biomarker panel had higher sensitivity for any grade of dysplasia than the Seattle protocol (81.5% vs 51.9%; P < .001) in the overall histology analysis, but not in the trial histology analysis (91.4% vs 80.0%; P = .16), with an area under the receiver operating curve of 0.83.
    Conclusions: Seattle protocol biopsies miss dysplasia in approximately half of patients with inconspicuous neoplasia. AFI-guided pCLE has similar accuracy to the current gold standard. The addition of molecular biomarkers could improve diagnostic accuracy.
    MeSH term(s) Humans ; Barrett Esophagus/complications ; Esophagoscopy/methods ; Tumor Suppressor Protein p53 ; Esophageal Neoplasms/pathology ; Microscopy, Confocal/methods ; Biopsy ; Hyperplasia ; Biomarkers/analysis ; Aneuploidy ; Randomized Controlled Trials as Topic
    Chemical Substances Tumor Suppressor Protein p53 ; Biomarkers
    Language English
    Publishing date 2022-02-17
    Publishing country United States
    Document type Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2022.01.060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Initiative to improve detection of faecal incontinence in primary care: The GIFT Project.

    Ribas, Yolanda / Coll, Meritxell / Espina, Avelina / Jiménez, Concepció / Chicote, Montserrat / Torné, Marta / Modolell, Ines

    Family practice

    2017  Volume 34, Issue 2, Page(s) 175–179

    Abstract: Background: Faecal incontinence (FI) is a distressing condition with a significant impact on quality of life. The true prevalence of FI is unknown but probably underestimated. Identifying patients affected is of key importance because a significant ... ...

    Abstract Background: Faecal incontinence (FI) is a distressing condition with a significant impact on quality of life. The true prevalence of FI is unknown but probably underestimated. Identifying patients affected is of key importance because a significant proportion may improve with conservative treatments, and there are a number of other treatments available.
    Objectives: The aim of our project was to improve detection of FI in our primary care setting.
    Methods: A multidisciplinary working group was created in order to raise awareness and educate health professionals about FI. We designed a simple protocol and organized educational meetings at 7 primary care centres. The usual diagnostic computer-based tools used by nurses were modified, so that FI was systematically asked about. A proactive attitude among doctors and midwives regarding FI was recommended for high-risk patient groups.
    Results: The project was implemented in October 2014. Before the intervention, only 250 (<1%) patients with a diagnosis of FI were identified from the primary care register out of a population over 165000 people. Between October 2014 and February 2016, 17370 patients were questioned about anal continence in routine follow-ups. Of those questioned, 829 (4.8%) disclosed suffering from FI. Mean age was 78.5 ± 14 years (16-104), 565 (68.2%) were females, and 264 (31.8%) were males. The percentage of patients with FI increased with age and was higher in women.
    Conclusion: Our results show that a proactive approach with direct questions on FI may lead to a significant increase in FI detection in primary care.
    MeSH term(s) Aged ; Fecal Incontinence/diagnosis ; Fecal Incontinence/epidemiology ; Female ; Health Personnel/education ; Humans ; Male ; Mass Screening ; Prevalence ; Primary Health Care ; Quality of Life ; Risk Factors
    Language English
    Publishing date 2017--01
    Publishing country England
    Document type Journal Article
    ZDB-ID 605939-9
    ISSN 1460-2229 ; 0263-2136
    ISSN (online) 1460-2229
    ISSN 0263-2136
    DOI 10.1093/fampra/cmx004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic

    di Pietro, Massimiliano / Modolell, Ines / O039, / Donovan, Maria / Price, Catherine / Pilonis, Nastazja D / Debiram-Beecham, Irene / Fitzgerald, Rebecca C

    Lancet Gastroenterol Hepatol

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #688798
    Database COVID19

    Kategorien

  8. Article ; Online: Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.

    Di Pietro, Massimiliano / Modolell, Ines / O'Donovan, Maria / Price, Catherine / Pilonis, Nastazja D / Debiram-Beecham, Irene / Fitzgerald, Rebecca

    2020  

    Abstract: During the COVID-19 pandemic, endoscopy services have been severely curtailed—eg, in England, UK, a 30% reduction of diagnostic endoscopies has been reported for the period between January and April, 2020, compared with the same period in 2019, with an ... ...

    Abstract During the COVID-19 pandemic, endoscopy services have been severely curtailed—eg, in England, UK, a 30% reduction of diagnostic endoscopies has been reported for the period between January and April, 2020, compared with the same period in 2019, with an estimated 750 oesophagogastric cancers going undiagnosed. A delay in oesophageal cancer diagnosis could adversely affect outcomes, such as has previously been seen with low endoscopy referral rates being linked with poor outcomes from oesophageal cancer.
    Keywords covid19
    Language English
    Publisher Elsevier
    Publishing country uk
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic

    di Pietro, Massimiliano / Modolell, Ines / O'Donovan, Maria / Price, Catherine / Pilonis, Nastazja D / Debiram-Beecham, Irene / Fitzgerald, Rebecca C

    The Lancet Gastroenterology & Hepatology

    2020  Volume 5, Issue 9, Page(s) 805–806

    Keywords Hepatology ; Gastroenterology ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2468-1253
    DOI 10.1016/s2468-1253(20)30242-9
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Proton-pump inhibitors in sleep-related breathing disorders: clinical response and predictive factors.

    Modolell, Inés / Esteller, Eduard / Segarra, Francesc / Mearin, Fermín

    European journal of gastroenterology & hepatology

    2011  Volume 23, Issue 10, Page(s) 852–858

    Abstract: Background and aim: Gastroesophageal reflux is frequently associated with sleep-related breathing disorders. We aimed to evaluate the prevalence of acid reflux in patients with sleep-related breathing disorders, their clinical response to proton-pump ... ...

    Abstract Background and aim: Gastroesophageal reflux is frequently associated with sleep-related breathing disorders. We aimed to evaluate the prevalence of acid reflux in patients with sleep-related breathing disorders, their clinical response to proton-pump inhibitor (PPI) treatment, and to identify predictive response factors to this treatment.
    Methods: Prospective study among patients attending a sleep clinic. Evaluation of typical and atypical gastroesophageal reflux symptoms, simultaneous 24 h dual-channel pH monitoring and polysomnography were performed in all patients. Patients were treated with pantoprazole. After 3-6 months clinical response was evaluated, and pHmetry and polysomnography repeated. Clinical response was defined in terms of snore, apnea and somnolence grading. Improvement in polysomnography was defined by the Stanford criteria.
    Results: One hundred and ninety-nine patients were included. Abnormal reflux levels were detected in the distal esophagus in 72% of patients, and in the proximal esophagus in 46%. Clinical or polysomnographic response to PPI treatment was found in 78% of patients. Pretreatment pHmetry was a significant predictor of success: 67% of responders had pathological proximal pHmetry (vs. 33% of nonresponders; P<0.001), and 55% also had pathological distal pHmetry (P<0.05). Age, sex, BMI, alcohol or tobacco abuse, typical or atypical gastroesophageal reflux symptoms, severity of sleeping disorder, and polysomnography were not predictive of outcome.
    Conclusions: Patients with sleep-related breathing disorders have an increased prevalence of gastroesophageal reflux disease. They may be successfully treated with PPIs, particularly in patients with an abnormal proximal esophageal pHmetry.
    MeSH term(s) 2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use ; Adult ; Aged ; Esophageal pH Monitoring ; Female ; Gastroesophageal Reflux/complications ; Gastroesophageal Reflux/drug therapy ; Humans ; Male ; Manometry/methods ; Middle Aged ; Polysomnography/methods ; Prognosis ; Proton Pump Inhibitors/therapeutic use ; Severity of Illness Index ; Sleep Apnea Syndromes/etiology ; Treatment Outcome ; Young Adult
    Chemical Substances 2-Pyridinylmethylsulfinylbenzimidazoles ; Proton Pump Inhibitors ; pantoprazole (D8TST4O562)
    Language English
    Publishing date 2011-10
    Publishing country England
    Document type Clinical Trial ; Journal Article
    ZDB-ID 1034239-4
    ISSN 1473-5687 ; 0954-691X
    ISSN (online) 1473-5687
    ISSN 0954-691X
    DOI 10.1097/MEG.0b013e328349d093
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top